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ABSTRACT 
Supercritical fluid chromatography (SFC) is frequently used for the analysis and 
separation of non-polar metabolites, but remains relatively underutilised for the study 
of polar molecules, even those which pose difficulties with established reversed-
phase (RP) or hydrophilic interaction liquid chromatographic (HILIC) methodologies. 
Here, we present a fast SFC-MS method for the analysis of medium and high-
polarity (-7 ≤ cLogP ≤ 2) compounds, designed for implementation in a high-
throughput metabonomics setting. Sixty polar analytes were first screened to identify 
those most suitable for inclusion in chromatographic test mixtures; then, a multi-
dimensional method development study was conducted to determine the optimal 
choice of stationary phase, modifier additive and temperature for the separation of 
such analytes using SFC. The test mixtures were separated on a total of twelve 
different column chemistries at three different temperatures, using CO2-methanol-
based mobile phases containing a variety of polar additives. Chromatographic 
performance was evaluated with a particular emphasis on peak capacity, overall 
resolution, peak distribution and repeatability. The results suggest that a new 
generation of stationary phases, specifically designed for improved robustness in 
mixed CO2-methanol mobile phases, can improve peak shape, peak capacity and 
resolution for all classes of polar analytes. A significant enhancement in 
chromatographic performance was observed for these urinary metabolites on the 
majority of the stationary phases when polar additives such as ammonium salts 
(formate, acetate and hydroxide) were included in the organic modifier, and the use 
of water or alkylamine additives was found to be beneficial for specific subsets of 
polar analytes. The utility of these findings was confirmed by the separation of a 
mixture of polar metabolites in human urine using an optimised 7 min gradient SFC 
method, where the use of the recommended column and co-solvent combination 
resulted in a significant improvement in chromatographic performance. 
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1. Introduction 
Supercritical fluid chromatography (SFC) as a viable separation technique was first 
reported by Klesper et al in 1962 [1]; the decades since have seen a steady increase 
in its reported use [2] for an ever-expanding range of applications [3]. However, 
unlike liquid chromatography (LC) or gas chromatography (GC), SFC has remained 
a niche technique for most of its history, primarily used for chiral separations or for 
preparative chromatography in industrial settings. Instrumental limitations played an 
important role in slowing the growth of analytical SFC, as many early instruments 
exhibited (amongst other issues) poor pump performance resulting in unstable 
backpressures [4]. An important factor driving the current resurgence of interest in 
the field has thus been the development of a new generation of SFC instruments, 
which provide substantial improvements in system reliability and performance over 
their predecessors, and are supplied with purpose-built interfaces for facile coupling 
to mass spectrometers [5].  These new instruments have been developed at a time 
of significant advances in column technology, including the widespread availability of 
columns packed with sub-3 µm porous shell particles and sub-2 µm totally porous 
particles [6]. Column manufacturers have responded to the surge in SFC use by 
offering columns specifically designed for improved stability in mixed CO2-methanol 
mobile phases [7]. Considered together, these developments indicate that SFC has 
the potential to develop into a mainstream mode of chromatography and, as 
discussed in a recent comprehensive review of the technique, may yet become as 
valued and widespread a tool as reversed-phase (RP) LC [8]. 
SFC is often described as an alternative to normal phase chromatography, without 
the requirement for problematic organic solvents, such as heptane [9]. Several 
recently reported achiral SFC applications have involved relatively non-polar 
analytes (e.g. various classes of lipids [10-12], organic pesticides [13], fat-soluble 
vitamins [14] etc.). Polar analytes have been more sparingly studied, even though 
Berger and others have shown that moderately polar pharmaceutical compounds 
can be separated on polar stationary phases by the addition of organic co-solvents 
(‘modifiers’) containing selected additives to the CO2 mobile phase [15]. Modifier 
addition can increase the solubility of polar analytes in the mobile phase, and via 
adsorptive processes can alter stationary phase characteristics with consequent 
changes in retention, selectivity and efficiency [9, 16]. Methanol is a popular choice 
as mobile-phase modifier in SFC, as it has been shown to improve the efficiency and 
peak shape for polar analytes on a variety of stationary phases; this improvement 
has been attributed to the superior hydrogen-bonding ability of methanol in 
comparison to other tested modifiers such as acetonitrile [17]. Modifier enrichment 
with neutral, acidic or basic additives has also been shown to reduce peak tailing 
and retention for polar analytes to different extents, depending upon the additive type 
as well as analyte characteristics, including their octanol/water partition coefficients, 
relative acidity, molecular size and functional group topology [18-20]. These findings 
have led to the suggestion that, with the appropriate combination of stationary 
phase, modifier and modifier additive, SFC methods can be developed to replace 
many RPLC or hydrophilic interaction liquid chromatography (HILIC) methods for 
polar compound analysis [8].     
One potential application area for SFC is metabolic phenotyping, also commonly 
referred to as metabonomics or metabolomics. Metabolic phenotyping determines 
metabolite profiles for biofluids and tissues in order to detect systemic responses to 
pathophysiological stimuli and to derive a comprehensive, systems-level 
understanding of health and disease [21]. Both targeted and untargeted metabolic 
phenotyping are beginning to be applied to very large-scale studies (ranging from 
many hundreds to thousands of samples), derived from preclinical, clinical and 
epidemiological investigations. Currently, the major analytical platforms used in 
metabolic phenotyping include nuclear magnetic resonance (NMR) spectroscopy, as 
well as GC and UHPLC coupled with mass spectrometry (i.e. GC-MS, UHPLC-MS) 
[22]. For UHPLC-MS-based profiling of polar, hydrophilic metabolites, HILIC and ion-
pair chromatography (IPC) have been employed with some success. However, the 
analysis of hydrophilic metabolites remains challenging, since HILIC is not a solution 
for all compounds, and IPC can lead to problematic long-term contamination of the 
MS [23]. This represents a major difficulty for metabolic phenotyping, as many of 
these chromatographically challenging metabolites represent key intermediates 
within important anabolic and catabolic biological processes, such as central carbon 
metabolism. At present, the lack of readily implementable LC-based technologies for 
the comprehensive and routine profiling of these compounds is therefore a 
significant constraint on our ability to monitor some basic biochemical differences 
between normal and diseased (e.g. cancerous) cells. New separation strategies 
such as SFC, which increase metabolome coverage while reducing solvent 
requirements, are consequently of great interest to metabolic phenotyping studies.  
Here, we report the development of an SFC-MS method for the analysis of polar 
analytes in urine, designed for implementation in a high-throughput metabolic 
phenotyping environment. An initial compound screening study, to identify polar 
analytes suitable for use in chromatographic test mixtures, was followed by a 
comprehensive method development study, designed to identify the best choice of 
stationary phase, modifier additive and temperature for the separation of test 
compounds using SFC. A total of twelve columns, nine modifier additives and three 
temperatures were tested during method development; methanol was used as the 
organic modifier throughout the study, with orthogonality and selectivity 
considerations driving the selection of both column and modifier additive. The 
chromatographic performance of each evaluated set of conditions (column, modifier 
and temperature) was judged based on calculated peak base widths, total resolution 
and the normalised product of the resolution, with the first two parameters used to 
compare relative peak capacities across conditions. The results suggest that a new 
generation of bridged ethylene hybrid (BEH) stationary phases, specifically designed 
for SFC analysis, is particularly well suited for the separation of a wide range of polar 
analytes, with diol and 2-picolylamine chemistries yielding significant improvements 
in chromatographic performance. It was also observed that the presence of 
ammonium formate, water or ammonium hydroxide in the methanol modifier can 
substantially improve chromatographic separation of highly polar metabolites. In 
addition, the use of alkylamines as modifier additives is strongly recommended for 
the analysis of basic analytes when the SFC is coupled to a UV-VIS detector. The 
utility of these findings was confirmed by separating a subset of polar analytes in 
human urine using the Torus Diol column with 20mM ammonium formate in 
methanol as an organic modifier, and comparing the results to conditions currently in 
general use for polar analyte separation on SFC.   
 
2. Materials and methods 
2.1 Solvents and solvent additives 
LC-MS (Chromasolv) grade methanol, acetonitrile and isopropanol were purchased 
from Sigma-Aldrich (Poole, UK); water was obtained from an ultra-pure water 
purification system (Millipore, UK) and ‘food fresh’ liquid CO2 (99.8% purity) was 
obtained from BOC (UK). Formic acid (98%), acetic acid (for LC-MS), ammonium 
formate (≥99.0%), ammonium acetate (≥99.0%), ammonium hydroxide solution 
(~10% in water, for HPLC), isopropylamine (99%), isobutylamine (99%) and 
isopentylamine (99%) were also purchased from Sigma.  
 
2.2 Compound library screening 
2.2.1 Composition of screened library  
Table S1 lists all sixty polar compounds tested during the compound screening 
study; these were obtained as pure solids of ≥95% purity from Sigma, with the 
exception of L-histidine and cytosine, which were purchased from Alfa Aesar 
(Heysham, UK). The selected compounds covered a cLogP range (calculated using 
ChemAxon [24]) from +1.2 to -6.5, a cLogD range (calculated using a pH of 5.5 and 
the ACD/Labs Percepta platform [25]) from 0.3 to -6.2, and molecular weights up to 
505 Da.  5 mL stock solutions of each of the 60 analytes were prepared in water or 
methanol and stored at -20 °C before use. Immediately prior to analysis, the stock 
solutions were diluted in 1:1 methanol:water to obtain a 10 µg/mL solution of each 
analyte; 1 µL of this dilute solution was injected onto the column for analysis. 
 
2.2.2 Chromatography for library screening 
Compound screening was performed on a Waters ACQUITY UPC2, consisting of a 
binary solvent manager, a sample manager held at 4°C and fitted with a 10 µL 
injection loop, an insulated column compartment with an active pre-heater and 
column heater, a PDA detector fitted with an 8 µL flow-cell, and a convergence 
manager containing an automated backpressure regulator (ABPR) with both static 
and dynamic components to control post-column system pressure. All injections 
were performed in partial loop (needle overfill) mode, and PDA data were collected 
between 190 and 400 nm for all analyses.  
Compounds were analysed on a fully-porous 3.00 x 100 mm, 1.7 µm ACQUITY 
UPC2 BEH 2-ethylpyridine (BEH 2-EP) column maintained at 35°C, using a mobile 
phase composed of CO2 (solvent A) and the selected organic modifier (solvent B) 
with the following 14.65 min gradient elution method: the mobile phase composition 
changed from 98% A at 0 min to 50% B at 10 min, was held at 50% B for 1 min, then 
returned to 98% A in 0.65 min, followed by re-equilibration at initial conditions till the 
end of the run. The flow-rate was 1 mL/min or 1.2 mL/min, depending upon whether 
isopropanol or methanol (respectively) was used as modifier. Four different organic 
modifiers were used to analyse each compound, viz. 5% v/v water in methanol, 20 
mM ammonium formate in methanol, 0.2% v/v formic acid in methanol and 7% v/v 
water in isopropanol. Each of these modifiers and additives has been successfully 
employed elsewhere for SFC analysis of polar moieties [26] [15]. 
 
2.2.3 Mass spectrometry for library screening 
The Waters UPC2 was coupled to a Waters Quattro Premier tandem mass 
spectrometer via a purpose-built, two-part stainless steel splitter supplied by Waters. 
The flow from the PDA detector was mixed with 0.2 mL/min makeup solvent (0.1% 
v/v formic acid in methanol), supplied by a Waters 515 HPLC pump, and the ABPR 
was used to maintain the resultant solvent stream at a pressure of 2000 psi (138 bar) 
throughout the run. The pressurised stream was directed into the ESI sample 
capillary via a length of 50 µm PEEKsil tubing.   
Compounds were detected by selected ion recording (SIR) in either positive or 
negative ESI MS mode, based on the known ionisation preference or optimal 
ionisation mode for each analyte. Source conditions in positive mode were as 
follows: capillary voltage 3.5 kV, cone voltage 30 V, source temperature 120°C, 
desolvation temperature 250°C, cone gas flow 300 L/hr and desolvation gas flow 
700 L/hr. Source conditions for negative mode were as follows: capillary voltage 3.0 
kV, cone voltage 30 V, source temperature 100°C, desolvation temperature 250°C, 
cone gas flow 50 L/hr, desolvation gas flow 500 L/hr. Analyser collision cell entrance 
and exit voltages were set at 50 V, with the collision cell voltage set at 2 V. SIR data 
was collected with a dwell time of 0.05 s and a cone voltage of 30 V (this was found 
to be suitable for the majority of analytes studied). Data acquisition, data handling 
and instrument operation were controlled by MassLynx (v. 4.1 from Waters, Milford 
MA, USA); raw SFC-MS and SFC-PDA data was subsequently processed and 
analysed using TargetLynx, a MassLynx module.     
 
2.3 Method development 
Scheme 1 illustrates the experimental design followed during chromatographic 
method development.  An initial set of eight columns were screened in nine co-
solvent additives and at three temperatures, with results evaluated based on 
improvements in peak capacity and peak distribution (cf. section 3.2). The four Torus 
columns were released in October 2014, after the study had commenced; in order to 
minimise the total number of experiments, these columns were accordingly only 
screened in the three MS-compatible modifiers that had yielded the best 
performance till that date. In addition, changing the temperature in the range initially 
selected for evaluation (35-45°C) did not lead to significant alterations in peak width 
or distribution. Consequently, the Torus columns were evaluated at one additional 
temperature, 55°C, in the three selected co-solvents. Thus a total of 264 unique 
combinations of column, modifier additive and column temperature were tested as 
part of the method development study. 
 
2.3.1 Test mixture preparation and extraction of human urine 
In the initial compound screening study, eleven compounds were identified as 
‘responders’, which eluted in all four organic modifiers with acceptable k values and 
peak symmetries. An additional nine compounds eluted in all four modifiers with 
either a k or a b/a value that fell outside the acceptable limits for a ‘hit’; these were 
considered to be ‘sub-responders’. The eleven responders and nine sub-responders 
(a total of twenty compounds) were subsequently incorporated into five different test 
mixtures in 1:1 methanol:water, as described in Table S2.The test mixtures were 
designed to cover a range of cLogP values and compound classes, and all contained 
caffeine as an internal standard for the measurement of analytical repeatability. Test 
mixtures were prepared in bulk as 25 mL solutions, and stored in 1 mL aliquots at -
20°C until immediately before analysis. 
For the separation of analytes in human urine, urine samples were obtained from 
healthy individuals and pooled to form a reference urine sample; this was spiked with 
caffeine, uridine and cytosine as aqueous stock solutions. The spiked urine was then 
mixed with methanol in a 1:3 urine:methanol ratio, vortexed for 30 s at room 
temperature, and centrifuged at 700 g at 4°C for 10 min. The centrifuged sample 
was divided into 1 mL aliquots and stored at -80°C, then thawed immediately prior to 
analysis. 
 
2.3.2. Stationary phases 
All columns screened during method development had dimensions of 3.00 mm i.d. x 
100 mm, and were obtained from Waters (Milford, USA). In all, twelve fully-porous 
columns were tested, including four Acquity UPC2 columns (BEH 2-EP, BEH, CSH 
FP and HSS C18 SB), four Acquity UPLC columns (BEH Amide, BEH HILIC, BEH 
Phenyl and HSS Cyano), and four Acquity UPC2 Torus columns (2-picolylamine or 2-
PIC, Diol, Diethylamine or DEA and 1-amino anthracene or 1-AA). Of these, only the 
HSS columns had a particle size (dp) of 1.8 µm, the remainder having a dp of 1.7 µm.  
The columns were tested for compliance with manufacturer QC specifications, and 
equilibrated in 100% CO2 at 1 mL/min for 60 min before initial use. Column 
performance was monitored at the start of each day of analysis using repeated 
injections of caffeine, adenosine and toluene (used as an approximate measure of 
column dead-volume by UV [27]) and an isocratic method with 5% (v/v) water in 
methanol as the organic modifier. Between analyses, columns were washed with 1:1 
CO2: methanol at 1 mL/min for 50 min, then stored in 100% CO2. 
 
2.3.3 Modifier preparation 
Methanol was used as the organic modifier throughout the method development 
phase, and contained one of nine different additives at a concentration of 0.5% v/v 
(for formic acid, acetic acid, isopropylamine, isobutylamine and isopentylamine), 
20mM (for ammonium formate, acetate and hydroxide), or 5% v/v (for water). All 
modifier solutions were prepared volumetrically or, in the case of the ammonium 
salts, by addition of the solid salt to the methanol, followed by sonication at room 
temperature for 10 min.  
 
2.3.4 Chromatography for method development 
A 7.35 min gradient elution method was used for all method development analyses, 
viz. 98% CO2 at 0 min to 50% CO2 at 4 min, held at 50% CO2 for 1.5 min, then 
returning to 98% CO2 in 0.8 min and re-equilibration till the end of the run; the 
column was held at the relevant temperature (35, 40, 45 or 55°C) and the flow-rate 
was kept constant at 1.0 mL/min throughout the run. Prior to all gradient analyses, 
columns were equilibrated at 1 mL/min for 20 min (>10 column volumes) at initial 
gradient conditions. 4 x 1 µL injections of caffeine were then made, and the 
observed retention time stability and peak area variation under gradient conditions 
were used to confirm column equilibration. This was followed by 2 µL injections of 
each test mixture. For human urine analysis, the same chromatographic gradient 
was used on both the BEH 2-EP and the Torus Diol columns at 40°C, using either 
5% water in methanol or 20 mM ammonium formate in methanol as modifier; 1 µL 
aliquots of 1:3 urine:methanol extract were injected onto the column. 
2.3.5 Mass spectrometry for method development 
MS analysis for method development was performed in ESI positive mode, with 
instrument configuration, source and analyser settings as given in Section 2.2.3, with 
the following modifications: extractor voltage 5 V and RF lens voltage 0.2 V. The flow 
from the PDA detector was mixed with 0.3 mL/min makeup solvent (0.1% v/v formic 
acid in methanol), supplied by a Waters 515 HPLC pump, before entering the MS 
source; the ABPR was held at 2000 psi (138 bar) for all analyses.  When alkylamines 
were used as modifier additives, the UPC2 was used in stand-alone mode i.e. with 
UV-VIS detection only.  
 
2.3.6 Data analysis 
Retention time (tR), peak area, peak base width, peak asymmetry (b/a) and signal-to-
noise (S/N) values for each analysis were obtained by processing the raw data in 
TargetLynx. Further statistical treatment was performed in R [28]. Venn diagrams 
were generated using the VennDiagram package [29]. Tukey-style boxplots (with no 
outliers shown) were generated using the default graphics package, with whiskers 
extending to (at a maximum) 1.5x the inter-quartile range (IQR); n values 
accompanying each boxplot or in the figure captions describe the number of data 
points included per condition.  
 
3. Results and discussion  
3.1 Screening of polar urinary metabolites for test compound identification  
For the planned SFC method development study, it was necessary to identify a set 
of representative polar compounds that eluted with reasonable peak shapes and 
retention times in a variety of routinely-used chromatographic conditions. 
Accordingly, a library of 60 polar analytes of known biological significance or clinical 
relevance was screened using a BEH 2-EP column and an SFC gradient method 
with one of four different organic modifiers. The compound library (Fig 1 A, Table S1) 
included nucleobases and related compounds (e.g., uracil, adenosine, cytosine and 
cytidine), amino acids (e.g., methionine, tryptophan, lysine etc.,), organic acids (2-
aminobutyric acid, lactic acid) and sugars (glucose, galactose). The BEH 2-EP 
column was chosen for compound screening since it has been widely used for SFC 
separations of polar analytes. Similarly, the four selected modifiers have previously 
been used for polar compound analysis by SFC [26] [15].  
Any analyte which eluted with an acceptable peak shape (as measured by b/a<4), 2 
≤k≤20 and a S/N ≥ 3 in either MS mode was considered to be a ‘hit’; Fig 1 B 
summarises the corresponding hit-rate for all tested modifiers. Compounds that were 
‘hits’ in all modifiers were classified as ‘responders’, and subsequently formed the 
basis of chromatographic test mixtures for SFC method development. ‘Non-
responders’ were those compounds for which peaks were not observed in the 
presence of any modifier, in any MS mode, and were accordingly left out of 
chromatographic test mixtures. Fig S1 provides further details regarding the 
distribution of responders and non-responders in the various tested modifiers and 
MS modes.    
 3.2 Evaluation of chromatographic conditions 
Having selected a suitable subset of polar analytes for test mixture preparation, a 
method development study was performed to evaluate chromatographic 
performance in a total of 264 unique combinations of column, modifier additive and 
column temperature. The resultant dataset was information-rich and complex, with a 
wide range of peak base widths and retention times exhibited by the twenty analytes 
across the tested conditions. In order to reduce this complex dataset to a more 
tractable form, it was necessary to identify criteria that would simplify evaluation and 
comparison of the separation quality. As high-throughput untargeted LC- or SFC-MS 
metabolic phenotyping studies require high peak capacities and resolution within a 
short analysis time, the quality of separation for each combination of column, 
modifier and temperature was evaluated based on three parameters: peak base 
width, sum of resolution and the normalised product of the resolution.  
The peak base width may be related to peak capacity as follows: 
 = 1 +


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
                                        (1) 
where Pc is the peak capacity for a gradient of length tg,  and wp is the base width for 
each of n peaks used in the calculation [30]. Another common definition of peak 
capacity uses the sum of the resolution (ΣR) across the chromatogram: 
 = 1 + ∑                                         (2) 
where RS is the resolution between peaks, calculated here using equation 3: 
 =
	(,,)
(,,)
                   (3) 
where wp,n is the peak width for the nth peak, eluting at retention time tr,n. Both 
definitions for peak capacity have constraints on their use to describe gradient 
separations (e.g. equation 2 applies to situations where peak widths follow a similar 
pattern across the chromatogram [30]), but are sufficient for our purpose viz. 
comparison of separation quality under different chromatographic conditions.  
Thus, based on equations 1 and 2, the average peak base width and the average 
ΣR may be used to compare the relative peak capacities of the evaluated 
chromatographic conditions. In the current analysis, we have chosen to compare 
peak base width and resolution data using the boxplot representation, and hence are 
comparing the median rather than the average parameters across conditions; 
however, where relevant, we have also provided mean values within the text. 
One shortcoming of peak capacity as an estimate of chromatographic performance 
is that it does not take into account the distribution of peaks across the 
chromatographic window. While minimising peak base width and increasing 
resolution are crucial for improved separation in metabolic profiling studies, an even 
distribution of peaks across the retention time range ensures a more efficient use of 
chromatographic space. To evaluate peak distribution, Schoenmakers and others 
have used the normalised resolution product ( or NPR) [31]: 
 = ∏ ( ⁄ )                    (4) 
where  is the mean resolution for n peaks. Thus for n peaks, each with the same 
, the  would have a value of 1; separations with a more uneven distribution of 
peaks would have values  <<1. By considering the peak capacity together with the 
, a separation can be simultaneously optimised for greater analyte resolution and 
more even feature distribution.   
In the following sections, boxplots comparing peak base widths across modifiers or 
columns are based on data for a subset of polar analytes which eluted with 
reasonable peak shapes and k values in all investigated conditions, viz. 2-
aminobutyric acid, adenine, adenosine, creatinine, cytosine, hippuric acid, leucine, 
proline, uracil and xylitol. These analytes were selected in order to compare 
modifiers or columns with different total numbers of observed peaks i.e. in order to 
ensure that the comparison was based upon peaks observed in all evaluated 
conditions. On the other hand, the sum of resolution for each condition was 
necessarily calculated based on all observed peaks. Similarly, the  calculations 
used data from all observed peaks per condition. Note that the BEH Phenyl phase is 
excluded from all column performance evaluation plots shown below, due to the 
extremely poor peak shapes and separation observed when it was used for this set 
of analytes , regardless of the modifier additive or temperature used. 
 
3.2.1 Effect of modifier additives        
A total of nine modifier additives were tested during method development; of these, 
water, formic acid, acetic acid and the ammonium salts were MS-compatible. The 
remaining three additives were alkylamines, and their use was consequently 
restricted to SFC-UV-vis only. The impact of additive selection upon peak base 
widths and resolution in SFC-MS mode is shown in Fig 2: the three ammonium salts 
reduce the median peak base width considerably when compared to the acidic 
additives. This reduction is particularly pronounced for nucleobases and amines, in 
keeping with the basic nature of the ammonium salt additives. Thus the addition of 
ammonium hydroxide to the modifier resulted in a median peak base width of 17.3 s, 
as opposed to formic acid with a median width of 33.9 s (mean values are 26.5 and 
46.6 s respectively). The use of ammonium formate and water also resulted in 
narrower peaks, with median widths of 19.4 (mean of 25.6 s) and 20.1 s (mean of 
33.2 s) respectively. As illustrated by Fig 2 C and D, these general trends are evident 
in the performance of individual columns, and are even more pronounced for specific 
columns. However, the sum of resolutions (ΣR) was not significantly enhanced by 
any additive, ranging from a median value of 4.0 for ammonium acetate to 4.7 for 
water (Fig 2 B). In addition, peak distribution measured by  (Fig 3 A) followed a 
different trend, with the most even distribution seen for ammonium acetate (median  
of 0.39, mean of 0.42), and the most uneven observed for ammonium formate and 
water, with median  values of 0.23 and 0.20 respectively. Different modifier 
additives may thus be chosen based on the desired outcome e.g. ammonium 
acetate for more even peak distribution, ammonium hydroxide for reduction in peak 
width, or ammonium formate for reduced peak widths across a wider range of 
analytes. 
These results are, for the most part, in agreement with previous studies showing the 
utility of volatile ammonium salts for SFC-MS separation of polar molecules. Both 
ammonium formate and ammonium acetate increased the elution of highly polar 
pharmaceutically-relevant analytes from a cyano column [19], and both were found 
to improve chromatographic peak shapes for a range of doping agents separated on 
BEH and BEH 2-EP columns. The latter study also tested the variation in MS 
response with modifier additive and found that, in comparison to formic acid or 
ammonium hydroxide, both ammonium acetate and ammonium formate improved 
signal intensity for the majority of tested doping agents. Furthermore, the 
combination of ammonium formate with a small percentage (2% v/v) of water 
resulted in additional gains in signal intensity, and this combined mobile phase was 
subsequently used for the analysis of 110 doping agents in human urine by SFC-MS 
[32]. The current base width data supports the use of water as an additive to improve 
peak shapes for acids and sugars, while its use has previously been demonstrated 
to give sharper peaks for nucleobases on a variety of stationary phases, including 
diol, cyanopropyl and 2-EP [26]. In the current study, cytidine, the most strongly 
retained of the nucleobases tested, only eluted from the amide column when 5% 
water was used as an additive: this supports the findings of Taylor and other groups, 
and suggests that water could be used in combination with other additives to 
improve separation of the most polar analytes [20, 26].  Hamman et al have 
demonstrated that 0.1% ammonium hydroxide in methanol as a modifier improves 
peak shape and decreases retention of basic drugs on both ethylpyridine and diol 
columns [33], and have also tested the stability of silica-supported chiral stationary 
phases in the presence of this modifier under SFC conditions. Their results suggest 
only minor stationary phase degradation occurs over 100,000 column volumes. 
Thus, the four additives with the greatest reduction in median peak base width 
(ammonium formate, acetate, hydroxide and water) should all be considered for the 
analysis of polar urinary metabolites by SFC-MS, with the final choice of additive (or 
additive combination) determined by the desired outcome, such as the targeted 
analysis of a specific compound class.  
The three alkylamine additives were tested using UV-vis (PDA) detection only, due 
to concerns regarding ion suppression and MS source contamination. Their impact 
on chromatographic performance was evaluated based on the separation of the 
seven UV-active analytes present in the test mixtures viz. adenine, adenosine, 
creatinine, cytidine, cytosine, hippuric acid and uracil. Alkylamines have been used 
extensively as ion-pairing agents in LC, to increase retention and improve peak 
characteristics for small, basic analytes. Berger and Wilson showed that baseline 
resolution of drug mixtures (including a series of anti-depressants, anti-psychotics 
and stimulants) could be obtained by adding 0.5% v/v isopropylamine to a methanol-
based SFC mobile phase [34-36], while De Klerck et al have used isopropylamine in 
conjunction with TFA to increase enantioresolution in chiral SFC [37]. Similarly, 
Regalado et al used 25 mM isobutylamine as an additive in methanol for chiral and 
achiral SFC separations of a variety of drugs and drug metabolites [38]. Thus, both 
isobutyl- and isopropylamine were included in our modifier screen, along with 
isopentylamine to determine if the size of the alkyl side-chain contributes to 
chromatographic performance in SFC.  
The reduction in median peak base width obtained upon addition of alkylamines to 
the mobile phase is shown in Fig 4. The UV-vis data showed consistently narrower 
peaks than the MS data, as is evident when comparing median peak widths for the 
methanol/5% water modifier in Figs 2 A and 4 A. This difference between MS and 
UV data may indicate that further optimisation of MS settings and/or system volumes 
between column outlet and MS inlet is required. As shown in Fig 4 A, both the 
median peak base width and the peak base width range across conditions was 
significantly reduced in the presence of the alkylamine additives, when compared to 
results obtained with methanol/5% water as a modifier (the latter had a median peak 
base width of 7.0 s). The reduction in peak base width followed a clear trend based 
on the size of the alkyl side-chain, with isopropylamine showing the lowest median 
width (4.5 s) and isopentylamine showing the highest (5.0 s). The median ΣR 
parameter decreased in the same direction, from 4.0 s for isopropylamine to 3.1 s for 
isopentylamine. Mean values for both peak base widths and ΣR followed the same 
trends. These results are in keeping with the findings of Berger, Regalado and 
others, and suggest that alkylamine additives should be considered for SFC-UV-vis 
analysis of polar metabolites. Furthermore, while the evaluated alkylamines 
dramatically improve separation on all columns (except BEH Amide), smaller 
branched-chain alkyl groups appear to be preferable to larger ones. Amine additives 
are expected to decrease non-specific interactions between analyte and stationary 
phase by masking exposed silanols [39]. Thus, the observed size-dependent trend 
indicates that increasing the bulk of the akyl group reduces the interaction between 
amine and silanol groups, reducing the masking effect seen with smaller alkyl 
groups. As Fig 4 D illustrates, these general findings are also valid in the case of 
individual columns, with some exceptions: the use of isopentylamine as an additive 
resulted in the narrowest peaks for the BEH 2-EP column, while it was water rather 
than the alkylamines that provided the greatest decrease in peak widths for the BEH 
Amide column (7.1 s for water vs. 20.7 for isopentylamine). 
 
3.2.2 Effect of column chemistry 
A total of twelve stationary phases were evaluated during method development. Of 
these, eight were columns specifically marketed for SFC use, while the remaining 
four were columns for use with RPLC or HILIC separations on UHPLC systems. The 
tested SFC columns included both the recently introduced ACQUITY UPC2 Torus 
columns, designed for improved robustness and stability in mixed CO2-methanol 
mobile phases [7, 40], and the older ACQUITY UPC2 range.  The effect of column 
selection on peak widths and on the sum of resolution across a range of modifiers 
and temperatures in summarised in Fig 5, while Fig 3 B shows the differences in  
due to column type.  From Fig 5 A it is evident that the greatest reduction in peak 
base width was obtained by use of the Torus range of columns (in dark grey), and 
that the peaks on this column range were generally narrow. The Diol column had the 
lowest median peak width of 12.6 s (mean of 14.1 s), though the 2-PIC column had a 
very similar median width (13.4 s) (mean of 15.3 s). The only non-Torus columns to 
show comparable median peak width reduction and peak width range were the HSS 
C18 SB and BEH 2EP columns (median widths of 17.4 for both); however, as is 
evident in Fig 5 C, peak resolution on the Diol column was markedly better than on 
the BEH 2-EP column. The UPLC columns (in white) showed slightly higher median 
peak widths, but the variation in values across conditions was much higher than for 
the Torus UPC2 columns. The largest variation in peak width was observed for the 
CSH FP column, which also showed a relatively uneven distribution of peaks (Fig 3 
B). The trend in peak width values was also seen for every compound class, with 
both Diol and 2-PIC columns showing significant reductions in peak width for all 
classes of analyte. Indeed, all Torus columns showed marked reductions in both 
median peak base widths and the base width variation (range) for all tested analyte 
classes. When column performance was compared in individual co-solvents (Fig 5 
D) it became apparent that the overall trends observed in Fig 5 A and B were also 
applicable in specific cases: the Diol column had the lowest median peak widths in 
the presence of water and ammonium formate (12.6 and 11.3 s respectively), while 
the 2-PIC column had the lowest median width in formic acid (13.7 s). Note that Fig 5 
D also demonstrates the beneficial effect of using ammonium formate as an additive 
for this set of analytes, with narrower peak widths observed across all column types 
in the presence of this additive.    
Of the Torus columns, the Diol column also had the highest median ΣR value (7.8) 
in keeping with the peak base width reduction, and a relatively high median  of 0.39 
(Fig 3 B). In general, the more even peak distributions were observed for the Torus 
columns (with the exception of the 2-PIC), the BEH HILIC and HSS Cyano columns, 
while the BEH Amide and CSH FP had the most uneven distributions. Thus the 
Torus columns, and in particular the Diol column, offer improved resolution due to 
narrower peak base widths for all classes of polar analyte, and a relatively even 
distribution of peaks across the retention time range. 
 
3.2.3 Effect of temperature 
The temperature range initially evaluated (35-45°C) was selected because it 
encompasses the common operational temperature range for untargeted LC-MS-
based urine metabolomics [41], and is also well below the maximum recommended 
temperature for the majority of screened stationary phases (60°C for the UPC2 
columns and 90°C for the UPLC columns). The ABPR pressure setting used (2000 
psi/138 bar) ensured that on-column phase separation of the methanol-CO2 mixture 
was not expected to occur in the evaluated temperature range [42], and the relatively 
high proportion of modifier meant that the mobile phase density remained 
predominantly liquid-like during the gradient run. Thus, increasing the temperature 
can be expected to impact retention and resolution in a similar manner as in LC.  
All three temperatures initially studied showed similar median peak base width and 
ΣR values, with no definite trend observable for any particular class of compound 
(Fig S5 A and B). The results suggested that increasing temperature over this range 
conferred no significant advantage in terms of chromatographic performance; no 
consistent trends were discernable even when the temperature behaviour of 
individual columns or co-solvents (Fig S5 C and D respectively) was inspected.  
Accordingly, the temperature range was extended by testing one additional 
temperature, 55 °C, which is still below the maximum temperature recommended for 
the UPC2 columns. Only the Torus columns were screened at this higher 
temperature; the results are illustrated in Fig 6. While changing temperature from 35 
to 45°C did not significantly alter the median peak widths or total resolution, 
increasing temperature to 55°C resulted in a 3 s drop in median base width (from 
17.2 s at 35°C to 14.3 s at 55 °C). However, median ΣR values did not improve over 
the same temperature range, perhaps since most analytes eluted earlier at 55°C, so 
reducing resolution (Fig 6 C).  
The reduction in median peak width at 55°C was also observed for each column 
evaluated at this temperature (Fig 6 D). Together, these results suggest that peak 
capacity may be improved by increasing column temperature to 55°C, but that such 
an increase should be carefully weighed against the possible reduction in absolute 
resolution that accompanies the temperature change. In addition, since the highest 
recommended temperature for the Torus columns is 60°C, it may be wise to select a 
lower operating temperature to ensure column stability over the course of high-
throughput metabolomics experiments.  
 
3.2.4 Analytical repeatability1  
Within-day analytical precision was measured by monitoring the retention time and 
peak area variation of caffeine (present in each test mixture as an internal standard). 
The caffeine peak eluted relatively early in all conditions, when the mobile phase 
consisted predominantly of CO2 (rather than the organic modifier). This meant that 
the caffeine peak was also more susceptible to spray-pulsing or spray stability 
phenomena seen at the MS inlet in high percentages of CO2, and thus functioned as 
a sensitive indicator of such problems. As shown in Figs S3 and S4, while the 
variation in retention time (as measured by % RSD) was generally quite small, at < 
2% in all conditions, the area of the caffeine peak varied significantly both across 
modifiers and column types. Ammonium hydroxide had the highest median caffeine 
peak area variation of all the MS-compatible additives (16.3% vs. 10.0% for 
ammonium formate), meaning that the improvements in resolution obtained with this 
additive were accompanied by increased analytical variation. Surprisingly, both Diol 
and 2-PIC columns, with narrow peaks and higher sum of resolution, showed the 
highest variation in median caffeine peak area (16.9 and 13.9% respectively). Such 
high variation compares unfavourably with the BEH 2-EP column, which has the 
lowest peak area RSD of 2.1%. Given the low variability in retention time values 
across columns, the large variations in caffeine peak area were investigated further, 
and found to be indicative of spray pulsing into the ESI source. As such, this 
variation can be addressed by increasing the percentage of organic modifier in the 
mobile phase at the start of the gradient. Preliminary tests show that increasing the 
modifier content from 2 to 10% at the start of the gradient significantly reduces the 
observed variation in the caffeine peak area, and has the added advantage of 
reducing the gradient length without affecting overall separation. Since all of the 
tested polar analytes require the presence at least 14% modifier in the mobile phase 
                                                             
1
 ‘Repeatability’ is used here rather than ‘reproducibility’ following NIST recommendations for use of 
these terms [43] 
for elution, this increase in modifier content is unlikely to significantly reduce the 
efficacy of the method, even for early-eluting analytes. 
 
3.2.5 Analysis of human urine extract and polar standards  
The method development study described herein indicates that of the tested Waters 
columns, the Torus range should be the first choice for the analysis of any class of 
polar metabolite; similarly, the use of either ammonium salts or water as modifier 
additives should be considered when analysing such compounds using SFC. In 
order to confirm these findings, human urine was analysed using the 7.35 min 
gradient method on the Torus Diol column in the presence of either 5% water or 
20mM ammonium formate in methanol as a modifier. The results were compared to 
the analysis of the same urine sample on the BEH 2-EP column using the same set 
of modifiers, since this column is widely used for polar compound analysis by SFC.  
The utility of the findings from the method development study are evident in Figure 7, 
which shows the pronounced improvement in peak capacity and overall resolution 
upon selection of a suitable modifier additive and column. In Figure 7 A, the use of 
ammonium formate rather than water as modifier additive resulted in baseline 
separation of uridine and cytosine on the BEH 2-EP column and improved resolution 
on the Diol column; however, when the BEH 2-EP column was replaced by the Diol 
column, both peak shape (Fig 7 B) and resolution improved, regardless of which 
additive is used. Other Torus columns such as the 2-PIC can be used instead of the 
Diol without a significant loss of resolution or peak symmetry, and the combination of 
ammonium formate and water as modifier additives might improve separation more 
than the use of either one by itself. Overall, however, the Torus Diol column used 
with a methanol/ammonium formate modifier is a promising starting point for 
untargeted SFC analysis of medium polarity metabolites in urine. This was further 
confirmed by the elution of 45 out of the 60 compounds in the initial library using this 
combination of column and modifier at 40°C (Table S1), i.e. these conditions 
resulted in a 75% hit-rate for the polar metabolite library of interest, with the majority 
of analytes exhibiting excellent peak shape with little tailing. The majority of analytes 
which were not detected under these conditions were organic acids, such as lactic 
acid, and amino acids such, as histidine: in order to detect these, additional 
optimisation of MS source or solvent conditions, or the use of MRM analyses, may 
be required. Interestingly, adding both water and ammonium formate to the co-
solvent resulted in a lower hit-rate of 63%, all other conditions (column, temperature 
etc.) remaining the same; this suggests that simply combining modifier additives is 
not sufficient to improve performance, but must be accompanied by an optimisation 
procedure for each set of analytes.  
 
4. Conclusions  
The diversity of the molecular species involved in metabolic pathways is such that 
nearly any analytical platform is a viable tool for metabolic phenotyping. For UHPLC-
MS based metabolic profiling, RPLC is the preferred mode for the separation of 
many non-polar metabolites, such as lipids, while HILIC is often used to analyse 
more hydrophilic compounds; the polarity range covered by these chromatographic 
methods is substantial. Yet profiling certain compound classes remains challenging, 
either because they are poorly retained under RP conditions due to their high 
polarity, or because a robust HILIC method for the same analytes requires prolonged 
re-equilibration times between analyses [23]. In addition, both RP and HILIC 
methods are dependent on an uninterrupted supply of high-purity organic solvents 
such as methanol and acetonitrile, which (in a high-throughput environment) can 
impose significant operational costs associated with solvent purchasing and 
disposal. SFC thus offers an alternative to solvent-hungry LC-MS-based metabolic 
profiling, while simultaneously increasing the range of analysable metabolites due to 
its orthogonality to RPLC under the appropriate conditions.  
The results presented here demonstrate that SFC can indeed be used to 
successfully analyse the majority of polar urinary metabolites of interest in the cLogP 
range from 2 to -7. Of the twelve columns evaluated, the Torus columns were clearly 
preferable for such applications, with the Diol column in particular showing higher 
peak capacities (lower peak base widths and higher ΣR values) for all analyte 
classes, and a somewhat more even distribution of peaks (higher median  values 
overall). In addition, the Torus range has been designed to avoid the pronounced 
and continuous retention time shifts observed in SFC using conventional phases with 
methanolic modifiers (which have recently been attributed to the formation of methyl 
silyl ethers under mixed CO2-methanolic conditions); thus, these columns are most 
likely suited for applications with prolonged analysis times [40]. Of the six MS-
compatible additives studied, the ammonium salts generally resulted in lower base 
widths and higher overall resolution than the other additives; however, the increased 
analytical variation seen for ammonium hydroxide should be considered when 
selecting it as an additive. Alkylamine additives such as isopropylamine should also 
be considered for UV-active analytes, as these produced marked reductions in peak 
widths. However, the significant increase in peak capacities when using UV-VIS 
detection vs. MS detection suggests further optimisation of MS settings and/or the 
interface between SFC and MS is required. Finally, while the use of higher 
temperatures can reduce peak widths for the majority of columns, the choice of 
temperature must also be based on stability considerations for high-throughput 
experiments. 
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Figure Captions 
Figure 1. A shows the composition of the polar analyte library screened for test compound 
identification. A cLogP-based colorscale has been used in A, with yellow corresponding to 
higher cLogP values and dark red corresponding to the lower cLogP values; maltose and 
maltotriose had the highest molecular weights in the library, while caffeine and citric acid had 
the highest and lowest cLogD values respectively. B compares analyte hit-rate by co-
solvent; the percentage of analytes eluting with acceptable peak descriptors in each co-
solvent is listed in parentheses below the x-axis. 
Figure 2. Effect of additive selection on chromatographic performance in SFC-MS. A shows 
the variation in peak base widths and B the differences in the sum of the resolutions (for all 
evaluated columns and all temperatures) with co-solvent additive. C illustrates the 
improvement in separation observed when using 20mM ammonium formate (AmForm) as a 
modifier additive rather than 0.5% v/v formic acid (FA). Both TIC chromatograms show 
separation of the nucleobase test mixture (1:caffeine, 2:uracil, 3:adenosine, 4:cytosine and 
5:cytidine) on a Torus Diol column (3.00 i.d. x 100 mm, 1.7 µm dP) at 40°C, using the 7.35 
min gradient described in Section 2.3.4. D shows the effect of additive selection on peak 
base widths for all 7 columns in the initial test set, further expanding on the data shown in A; 
n = 30 for all plots and the red asterisks indicate the lowest median peak width value.  
Figure 3. Normalised product of resolution ( or NPR) for SFC-MS data. A shows the 
variation in NPR across modifier additives (for all evaluated columns and all temperatures), 
while B illustrates NPR variation across columns (for water, ammonium formate and formic 
acid-containing modifiers, at all temperatures); UPC2 columns are in light gray, Torus UPC2 
columns in dark gray and UPLC columns are in white. 
Figure 4. Effect of alkylamine additives on chromatographic performance in SFC (UV-vis 
data only). A shows the variation in peak base widths and B the differences in the sum of 
the resolutions (across all evaluated columns and all temperatures); the N value of 267 in A 
reflects the fact that some analytes were present in multiple test mixtures. C illustrates the 
improvement in separation observed when using 0.5% v/v isobutylamine (IsoButAm) as a 
modifier additive rather than 5% water (Wat). Both chromatograms show separation of the 
nucleobase test mixture (1:uracil, 2:adenosine, 3:cytidine, 4:cytosine) on an HSS Cyano 
column (3.00 i.d. x 100 mm, 1.8 µm dP) at 40°C, using the 7.35 min gradient described in 
Section 2.3.4. D shows the effect of additive selection on peak base widths for 4 
representative columns, further expanding on the data shown in A; n = 39 for all plots and 
the red asterisks indicate the lowest median base width value.    
Figure 5. Effect of column selection on chromatographic performance in SFC-MS. A shows 
the variation in peak base widths and B the differences in the sum of resolutions (across 
water, ammonium formate and formic acid-containing modifiers and all temperatures) by 
column. UPC2 columns are in light gray,Torus UPC2 columns in dark gray and UPLC 
columns are in white. C illustrates the improvement in separation observed when using a 
Torus Diol column rather than a BEH 2-EP column. Both TIC chromatograms show 
separation of the nucleobase test mixture (1:caffeine, 2:uracil, 3:adenosine, 4:cytosine and 
5:cytidine) using 20 mM ammonium formate in methanol as a modifier at 40°C, using the 
7.35 min gradient described in Section 2.3.4. D shows the effect of column selection on peak 
base widths for 3 representative co-solvents, further expanding on the data shown in A; n = 
45 for all plots and the red asterisks indicate the lowest median base width value.    
Figure 6. Effect of temperature on chromatographic performance in SFC-MS. A shows the 
variation in peak base widths and B the differences in the sum of resolutions (across water, 
ammonium formate and formic acid-containing modifiers and all Torus columns) by 
temperature. C illustrates the change in peak width and resolution observed when using a 
Torus DIOL column at 55°C rather than at 35°C. Both TIC chromatograms show separation 
of the nucleobase test mixture (1:caffeine, 2:uracil, 3:adenosine, 4:cytosine and 5:cytidine) 
using 20 mM ammonium formate in methanol as a modifier at the relevant temperature, 
using the 7.35 min gradient described in Section 2.3.4. D shows the effect of temperature 
selection on peak base widths for the Torus columns, further expanding on the data shown 
in A; n = 33 for all plots and the red asterisks indicate the lowest median base width value.    
Figure 7. Results of method development study for SFC separation of polar urinary 
metabolites. A illustrates the effect of column and modifier selection on chromatographic 
separation for polar analyte standards spiked into human urine (1:caffeine, 2:cytosine and 
3:uridine); in B, the cytosine peak from each separation shown in A is magnified, to show the 
improvement in peak symmetry upon replacement of the BEH 2-EP column with the Torus 
Diol column. 
Scheme Captions 
Scheme 1 Experimental design used for chromatographic method development. 
 
 
 
 
 
 
 
 
